NLH — Nova Leap Health Cashflow Statement
0.000.00%
Last trade - 00:00- CA$27.50m
- CA$29.48m
- $31.47m
Annual cashflow statement for Nova Leap Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1.76 | -0.836 | -1.05 | 1.38 | -0.19 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -0.397 | 1.24 | 2.58 | -1.14 | 1.17 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.596 | -0.11 | 0.1 | 0.242 | -0.187 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 2.18 | 1.02 | 2.15 | 1.39 | 1.56 |
| Capital Expenditures | 0 | -0.071 | -0.028 | -0.025 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -7.4 | 0.015 | 0.005 | -1.57 | -1.24 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -7.4 | -0.056 | -0.023 | -1.59 | -1.24 |
| Financing Cash Flow Items | -0.229 | -0.285 | -0.056 | -0.007 | -0.166 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.33 | -1.41 | -2.52 | 0.73 | -0.251 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.05 | -0.461 | -0.378 | 0.508 | 0.09 |